172 results
8-K
EX-3.1
787 dtl0zb47p5t1ym
17 Nov 22
Material Modifications to Rights of Security Holders
5:20pm
DEFA14A
n1vdrc7 9mrokqqe
30 Sep 22
Additional proxy soliciting materials
4:18pm
8-K
EX-2.1
31gjgz 06h
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.4
9a4w8ja kkn
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.5
tkg8791i
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
DEFA14A
EX-99.1
v2jo8
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.1
vlb9en
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
8-K
EX-99.1
w19f qftljhrq9h02
17 May 22
Idera Pharmaceuticals Shares Positive Results from Investigator- Sponsored Trial in Melanoma Patients at Amsterdam UMC
10:14am